Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable
- 1 March 2015
- journal article
- research article
- Published by Elsevier in Clínica e Investigación en Arteriosclerosis
- Vol. 27 (2) , 57-63
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2014
- 2013 ESC guidelines on the management of stable coronary artery diseaseEuropean Heart Journal, 2013
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease PredictionNew England Journal of Medicine, 2012
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)European Heart Journal, 2011
- C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection StudyThe Lancet, 2011
- Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and DeathNew England Journal of Medicine, 2006
- Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromesJACC, 2005
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- Prognostic Value of Myeloperoxidase in Patients with Chest PainNew England Journal of Medicine, 2003
- C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial InfarctionCirculation, 1998